Masimo Corporation (MASI) Given Consensus Rating of “Hold” by Brokerages

Masimo Corporation (NASDAQ:MASI) has been given a consensus recommendation of “Hold” by the six research firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $86.00.

Several research firms recently weighed in on MASI. Wedbush restated an “outperform” rating and set a $95.00 price target on shares of Masimo Corporation in a research report on Monday, February 27th. Piper Jaffray Companies lowered shares of Masimo Corporation from an “overweight” rating to a “neutral” rating in a research report on Thursday, March 16th. Finally, Zacks Investment Research lowered shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 11th.

In related news, CEO Joe E. Kiani sold 145,841 shares of the stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $102.37, for a total transaction of $14,929,743.17. Following the completion of the transaction, the chief executive officer now owns 165,082 shares in the company, valued at $16,899,444.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Joe E. Kiani sold 154,159 shares of the stock in a transaction dated Wednesday, April 26th. The shares were sold at an average price of $99.70, for a total transaction of $15,369,652.30. Following the transaction, the chief executive officer now owns 219,241 shares of the company’s stock, valued at approximately $21,858,327.70. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 562,201 shares of company stock valued at $56,005,386. 16.60% of the stock is owned by company insiders.

Institutional investors have recently modified their holdings of the company. BlackRock Inc. raised its position in shares of Masimo Corporation by 4,676.3% in the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock worth $686,789,000 after buying an additional 7,210,051 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Masimo Corporation by 5.9% in the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock worth $430,641,000 after buying an additional 258,719 shares in the last quarter. Janus Capital Management LLC raised its position in shares of Masimo Corporation by 0.5% in the fourth quarter. Janus Capital Management LLC now owns 2,703,291 shares of the medical equipment provider’s stock worth $182,202,000 after buying an additional 13,735 shares in the last quarter. State Street Corp raised its position in shares of Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after buying an additional 419,767 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Masimo Corporation by 45.0% in the first quarter. Acadian Asset Management LLC now owns 1,399,187 shares of the medical equipment provider’s stock worth $130,489,000 after buying an additional 434,389 shares in the last quarter. Hedge funds and other institutional investors own 83.48% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Masimo Corporation (MASI) Given Consensus Rating of “Hold” by Brokerages” was reported by WKRB News and is the property of of WKRB News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.wkrb13.com/markets/2231069/masimo-corporation-masi-given-consensus-rating-of-hold-by-brokerages.html.

Masimo Corporation (MASI) traded up 0.29% on Monday, reaching $91.11. 639,658 shares of the company were exchanged. The company’s 50-day moving average price is $89.56 and its 200-day moving average price is $83.01. The stock has a market capitalization of $4.66 billion, a P/E ratio of 15.47 and a beta of 0.89. Masimo Corporation has a 12-month low of $48.07 and a 12-month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, May 3rd. The medical equipment provider reported $0.82 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.22. The company had revenue of $186.30 million during the quarter, compared to the consensus estimate of $184.14 million. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.53 earnings per share. Equities research analysts anticipate that Masimo Corporation will post $2.66 earnings per share for the current fiscal year.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2231069/masimo-corporation-masi-given-consensus-rating-of-hold-by-brokerages.html

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.